Evidence map›Paper›PMID 21454508›Full record

ArticleThe Journal of biological chemistry2011

Structure of the tandem MA-3 region of Pdcd4 protein and characterization of its interactions with eIF4A and eIF4G: molecular mechanisms of a tumor suppressor.

Lorna C Waters, Sarah L Strong, Eva Ferlemann, Ojore Oka, Frederick W Muskett, Vaclav Veverka, Sreemoti Banerjee, Thore Schmedt, Alistair J Henry, Karl-Heinz Klempnauer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lorna C WatersDepartment of Biochemistry, Henry Wellcome Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, United Kingdom. lw83@le.ac.uk
Sarah L Strong
Eva Ferlemann
Ojore Oka
Frederick W Muskett
Vaclav Veverka
Sreemoti Banerjee
Thore Schmedt
Alistair J Henry
Karl-Heinz Klempnauer
Mark D Carr
University of Leicester · GBUniversity of Münster · DEUCB Pharma (United Kingdom) · GB

Funding

Wellcome TrustWellcome Trust 063632Wellcome Trust 080085Wellcome Trust 083629
6 · The paper itself

Abstract

One of the key regulatory points of translation initiation is recruitment of the 43S preinitation complex to the 5' mRNA cap by the eIF4F complex (eIF4A, eIF4E, and eIF4G). The tumor suppressor protein Pdcd4 has been shown to inhibit cap-dependent translation by interacting tightly with the RNA helicase eIF4A via its tandem MA-3 domains. The NMR studies reported here reveal a fairly extensive and well defined interface between the two MA-3 domains in solution, which appears to be stabilized by a network of interdomain salt bridges and hydrogen bonds, and reveals a unique orientation of the two domains. Characterization of the stoichiometry of the Pdcd4-eIF4A complex suggests that under physiological conditions Pdcd4 binds to a single molecule of eIF4A, which involves contacts with both Pdcd4 MA-3 domains. We also show that contacts mediated by a conserved acidic patch on the middle MA-3 domain of Pdcd4 are essential for forming a tight complex with eIF4A in vivo, whereas the equivalent region of the C-terminal MA-3 domain appears to have no role in complex formation in vivo. The formation of a 1:1 eIF4A-Pdcd4 complex in solution is consistent with the reported presence in vivo of only one molecule of eIF4A in the eIF4F complex. Pdcd4 has also been reported to interact directly with the middle region of eIF4G, however, we were unable to obtain any evidence for even a weak, transient direct interaction.

Indexed as

Gene Expression RegulationGenes, Tumor SuppressorAnimalsApoptosis Regulatory ProteinsEukaryotic Initiation Factor-4AEukaryotic Initiation Factor-4GGreen Fluorescent ProteinsHumansHydrogen BondingMagnetic Resonance SpectroscopyMicePlasmidsProtein BiosynthesisProtein Structure, TertiaryRNA-Binding ProteinsApoptosis Regulatory ProteinsEukaryotic Initiation Factor-4AEukaryotic Initiation Factor-4GGreen Fluorescent ProteinsPDCD4 protein, humanPdcd4 protein, mouseRNA-Binding Proteins

Identifiers

PMID21454508
PMCPMC3089569
OpenAlexW1982497227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.